▶️ Read Full Paper
📚 Source: Frontiers in neurology
👤 Creator: Aysenur Ince Kocoğlu et al.
📅 Date: 2026-09-18
#MigrainePapertag/MigrainePaper" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#MigrainePaper #Migraine/hashtag/Migraine" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#Migraine #PubMed="/hashtag/PubMed" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#PubMed
▶️ Read Full Paper
📚 Source: Frontiers in neurology
👤 Creator: Aysenur Ince Kocoğlu et al.
📅 Date: 2026-09-18
#MigrainePapertag/MigrainePaper" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#MigrainePaper #Migraine/hashtag/Migraine" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#Migraine #PubMed="/hashtag/PubMed" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#PubMed
RESULTS: Serum netrin-1 levels were markedly lower in the migraine group compared to the control group (🧵 3/8)
RESULTS: Serum netrin-1 levels were markedly lower in the migraine group compared to the control group (🧵 3/8)
▶️ 논문읽기
📚 출처: Frontiers in neurology
👤 저자: Aysenur Ince Kocoğlu et al.
📅 날짜: 2026년 09월 18일
🆔 PMID: 42755650
📄 PMC: PMC13581679
🔗 DOI: 10.3389/fneur.2026.1932356
#편두통논문g/%ED%8E%B8%EB%91%90%ED%86%B5%EB%85%BC%EB%AC%B8" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#편두통논문 #편두통hashtag/%ED%8E%B8%EB%91%90%ED%86%B5" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#편두통 #펍메드hashtag/%ED%8E%8D%EB%A9%94%EB%93%9C" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#펍메드
▶️ 논문읽기
📚 출처: Frontiers in neurology
👤 저자: Aysenur Ince Kocoğlu et al.
📅 날짜: 2026년 09월 18일
🆔 PMID: 42755650
📄 PMC: PMC13581679
🔗 DOI: 10.3389/fneur.2026.1932356
#편두통논문g/%ED%8E%B8%EB%91%90%ED%86%B5%EB%85%BC%EB%AC%B8" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#편두통논문 #편두통hashtag/%ED%8E%B8%EB%91%90%ED%86%B5" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#편두통 #펍메드hashtag/%ED%8E%8D%EB%A9%94%EB%93%9C" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#펍메드
▶️ www.nature.com/articles/s41467-025-59612-6
▶️ www.nature.com/articles/s41467-025-59612-6
https://www.biorxiv.org/content/10.64898/2026.06.01.729439v1
https://www.biorxiv.org/content/10.64898/2026.06.01.729439v1
https://www.biorxiv.org/content/10.64898/2026.05.17.725695v1
https://www.biorxiv.org/content/10.64898/2026.05.17.725695v1
https://www.biorxiv.org/content/10.1101/2025.04.28.650943v1
https://www.biorxiv.org/content/10.1101/2025.04.28.650943v1
Frontiers
www.frontiersin.org/journals/agi...
Frontiers
www.frontiersin.org/journals/agi...
要点1: UNC-6とUNC-40は局所粘着から方向性成長までを誘導
要点2: UNC-6は段階的に粘着と化学性のタクシスを刺激
(Note: This is a simplified summary of the provided abstract.)
要点1: UNC-6とUNC-40は局所粘着から方向性成長までを誘導
要点2: UNC-6は段階的に粘着と化学性のタクシスを刺激
(Note: This is a simplified summary of the provided abstract.)
要点1: PinocembrinとMCC950は、うつ病様行動を改善し、NLRP3およびNetrin-1/DCC経路を調整する。
要点2: Pinocembrinは、LPSによって誘発されたうつ病様行動を改善し、神経可塑性を向上させる。
要点1: PinocembrinとMCC950は、うつ病様行動を改善し、NLRP3およびNetrin-1/DCC経路を調整する。
要点2: Pinocembrinは、LPSによって誘発されたうつ病様行動を改善し、神経可塑性を向上させる。
📷 Hiba Haidar et al, Aix-Marseille University
in @natcomms.nature.com
➡️ bpod.org.uk/archive/2025...
📷 Hiba Haidar et al, Aix-Marseille University
in @natcomms.nature.com
➡️ bpod.org.uk/archive/2025...
➕Anti-SEMA5A/B
➕Anti-Slit-1
➕Anti-Netrin-1
➕Anti-Netrin-G1
Find your target: buff.ly/xmMjK5f
#sema #slit #netrin #netring
➕Anti-SEMA5A/B
➕Anti-Slit-1
➕Anti-Netrin-1
➕Anti-Netrin-G1
Find your target: buff.ly/xmMjK5f
#sema #slit #netrin #netring
IPI now offers #recombinantantibodies to all three targets, backed by solid validation data.
Explore our reagents: buff.ly/T1CktaD
IPI now offers #recombinantantibodies to all three targets, backed by solid validation data.
Explore our reagents: buff.ly/T1CktaD
Our new anti-DCC, anti-Netrin-1, and anti-IGDCC3 (PUNC) #antibodies come with full validation datasets—including demonstrated lack of #crossreactivity.
Take a closer look: buff.ly/LLL78N2
Our new anti-DCC, anti-Netrin-1, and anti-IGDCC3 (PUNC) #antibodies come with full validation datasets—including demonstrated lack of #crossreactivity.
Take a closer look: buff.ly/LLL78N2